Groupe BSH | Biomedical Engineering

Luponax – firstly called Plastics then renamed as BioMedical – is a specialist in white room plastic injection moulding for the medical sector. In the next few years, this sector will be making more use of plastics due to the multitude of benefits:

  • The optimisation of asepsis rules: Ease of cleaning and decontamination, disposable properties for certain materials.

  • The development of new treatments, in particular for orphan diseases, kidney diseases, etc.

  • Progress and continuous innovation on these materials:
    Bio-compatibility, bio-degradability, nanotechnologies, sterilisation capacity, etc.

  • Improvement in the quality of care: Outpatient surgery,
    Fight against nosocomial infections

  • Development of preventive medicine by diagnosis

  • Better cost-effectiveness than other materials.

    The BSH Group is well situated in Plastic Valley, one of the first European plastics clusters. This business park features a dense network of SME-SMIs, including raw materials suppliers, machine and equipment manufacturers, moulders, transformers, training organisations, research centres and the Plastipolis competitiveness cluster. Working in such a network enables the group to innovate and organise the partnership strategies required for its development.

 

Plasturgiste secteur médical, conception pièces thermoplastiques, pièces plastiques pharmaceutique,ISO 13485, Transformateur en salle blanche, Injecteur en salle blanche.

LUPONAX Plastic Biomedical quality certifications

LUPONAX Plastic Biomedical quality certifications
Innovative solutions are born from this innovation process. As an example, the syringe designed and developed by Luponax BioMedical for Biomatlante, who manufacture and distribute 100% synthetic dual-phase bone substitutes. This company designed an injectable synthetic bone filler material. It needed a specific syringe to be able to inject the dual-phase material (liquid and powder) into the patient.
The syringe had to offer features such as ensuring the homogeneity of the two phases and the sterility of the material during preparation. Together with the Biomatlante project team, the Luponax BioMedical R&D team optimised the manufacturing process and developed the product design. Lastly, each company's quality department integrated the regulatory requirements in terms of bio-contamination risk right from the design phase.

ISO TS 16949, an international standard applicable to automobile makers. Quality is an essential component of our policy: Material vigilance, qualification, product control, traceability.


Certifications
- ISO 9001 version 2008,
- ISO TS 16949 version 2009,
- ISO 13485 version 2004.

February 15th & 16th, 2012

Pharmapack

LUPONAX BIOMEDICAL will be at Pharmapack on February 15th & 16th, 2012, in Paris, Grande Halle de la Villette - Stand n° 363


November 16th to 18th, 2011

Salon MEDICA/COMPAMED

Luponax was at MEDICA/COMPAMED - HALL 8B F10. In Dusseldorf, Germany.


> View all news

Plastics experts, Medical sector plastics, medical plastics, pharmaceutical sector plastics, cleanroom transformer, cleanroom injector, cleanroom plastics, thermoplastic parts design, ISO 13485, medical plastic parts, pharmaceutical plastic parts, pharmaceutical plastics, medical plastics, pharmaceutical parts injection, diagnosis device injection, medical packaging injection, medical packaging, medical parts injection, implantable device injection, orthopaedic device injection, biocompatible device injection, bio-absorbable device injection, Radel injection, USP 6 materials injection, automated assemblies for medical devices, pharmaceutical device assembly, medical device design support, ISO 7classes, ISO 5 classes, ISO 8 class, sterile parts injection, plastic part sterilization.

Design : A3DIMENSIONS